Optiscan Imaging Limited

As of June 30, 2026, Optiscan Imaging Limited carries a market capitalization of 125.30M, placing it among publicly traded companies globally. Its enterprise value stands at 112.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Optiscan Imaging Limited has 1.04B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 266.36, and the price-to-book ratio stands at 6.61.

These figures are as of June 30, 2026. The EV/Sales ratio of 250.23 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 112.29M versus a market cap of 125.30M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Optiscan Imaging Limited maintains a current ratio of 10.85, meaning it holds 10.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.10, indicating elevated leverage, while an interest coverage ratio of -126.07 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Optiscan Imaging Limited posted a negative return on equity (ROE) of -52.41, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -42.88, reflecting losses generated across the asset base. Inventory turnover of 0.13 indicates how many times Optiscan Imaging Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Optiscan Imaging Limited recorded 12,646.00 in income tax expense. The company reported a pretax loss of -6.97M and -6.99M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Optiscan Imaging Limited's stock has gained approximately 29.17% over the past 52 weeks. The 50-day moving average sits at 0.16, while the 200-day moving average is 0.12.

Over the twelve months ended June 30, 2026, Optiscan Imaging Limited generated 448,769.00 in revenue and converted that into -6.99M in net income, yielding earnings per share of -0.01. EBITDA reached -10.28M, while operating income came in at -10.60M.

As of June 30, 2026, Optiscan Imaging Limited holds 14.35M in cash and equivalents against 1.34M in total debt, resulting in a net debt position of -14.32M. Total book value stands at 18.94M, with working capital of 18.50M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Optiscan Imaging Limited posted a gross margin of 41.53, reflecting its pricing power and cost economics. The operating margin of -2,362.67 and net profit margin of -1,556.71 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -13.70, meaning Optiscan Imaging Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Optiscan Imaging Limited's most recent stock split took place on September 1, 2025 with a 437:440 split ratio.

As of June 30, 2026, Optiscan Imaging Limited has an Altman Z-Score of 18.20, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.